HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hans Wadenvik Selected Research

Messenger RNA (mRNA)

7/2013MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS).
3/2013MicroRNA regulate immunological pathways in T-cells in immune thrombocytopenia (ITP).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hans Wadenvik Research Topics

Disease

14Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
02/2017 - 03/2002
10BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2022 - 01/2004
4Hemorrhage
02/2017 - 08/2002
4Autoimmune Diseases (Autoimmune Disease)
01/2015 - 07/2010
1Pleural Effusion (Pleural Effusions)
01/2022
1Sepsis (Septicemia)
01/2022
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2022
1Heart Failure
01/2022
1Myocardial Infarction
01/2022
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2022
1Pneumonia (Pneumonitis)
01/2022
1Blast Crisis (Blast Phase)
12/2016
1Second Primary Neoplasms (Neoplasms, Second)
06/2015
1Neoplasms (Cancer)
06/2015
1Multiple Sclerosis
07/2013
1Secondary Hyperparathyroidism
05/2012
1Osteomalacia
05/2012
1Osteoporosis
05/2012
1Wounds and Injuries (Trauma)
02/2012
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2011
1Thrombocytopenia (Thrombopenia)
07/2010
1Osteoarthritis
01/2004
1Pain (Aches)
01/2004
1Ankylosing Spondylitis
01/2004
1Philadelphia Chromosome
01/2004
1Inflammation (Inflammations)
01/2004
1Rheumatoid Arthritis
01/2004
1Arthritis (Polyarthritis)
01/2004
1Soft Tissue Injuries (Soft Tissue Injury)
01/2004

Drug/Important Bio-Agent (IBA)

13Inosine Triphosphate (ITP)IBA
02/2017 - 03/2002
9Imatinib Mesylate (Gleevec)FDA Link
01/2022 - 01/2004
4Tyrosine Kinase InhibitorsIBA
01/2022 - 01/2012
4AutoantibodiesIBA
02/2012 - 09/2003
2romiplostimFDA Link
02/2017 - 07/2010
2Therapeutic UsesIBA
12/2016 - 01/2004
2CytokinesIBA
01/2015 - 03/2002
2Messenger RNA (mRNA)IBA
07/2013 - 03/2013
2MicroRNAs (MicroRNA)IBA
07/2013 - 03/2013
1nilotinibFDA Link
01/2022
1Dasatinib (BMS 354825)FDA Link
01/2022
1insulin receptor-related receptor (IRR)IBA
01/2022
1AntibodiesIBA
12/2016
1Granzymes (Granzyme)IBA
06/2012
1Parathyroid Hormone (Parathormone)IBA
05/2012
1Autocrine Motility Factor ReceptorsIBA
12/2011
1Thrombopoietin (c-mpl Ligand)IBA
07/2010
1Peptides (Polypeptides)IBA
07/2010
1eltrombopagFDA Link
07/2010
1Phosphotransferases (Kinase)IBA
12/2006
1Analgesics (Analgesic Drugs)IBA
01/2004
1NabumetoneFDA LinkGeneric
01/2004
1Transforming Growth Factor beta1 (TGF beta 1)IBA
03/2002

Therapy/Procedure

4Therapeutics
01/2017 - 11/2004